Respiratory care of the surgical patient with cardiac disease.
This article describes the mechanisms by which cardiac disease, when combined with surgery and anesthesia, may tax the respiratory system beyond its capabilities. Techniques of respiratory support aimed at improving oxygenation, ventilation, and the work of breathing are examined.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D000402:Airway Obstruction / Q000139:chemically induced; D000777:Anesthetics / Q000009:adverse effects; D006331:Heart Diseases / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D006976:Hypertension, Pulmonary / Q000209:etiology / Q000503:physiopathology; D007385:Intermittent Positive-Pressure Ventilation / Q000009:adverse effects; D010100:Oxygen / Q000097:blood; D010102:Oxygen Inhalation Therapy; D012120:Respiration Disorders / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D012129:Respiratory Function Tests; D013514:Surgical Procedures, Operative / Q000009:adverse effects; D013903:Thoracic Surgery / Q000009:adverse effects; D014665:Vasodilator Agents / Q000009:adverse effects; D014939:Work of Breathing
D000319:Adrenergic beta-Antagonists; D000777:Anesthetics; D014665:Vasodilator Agents; D010100:Oxygen